Wang J, Kim CH (2022) Differential risk of cancer associated with glucagon-like peptide-1 receptor agonists: analysis of real-world databases
Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone in the intestines that regulates blood glucose levels, slows stomach emptying, and promotes a sense of fullness after eating 3
People taking the GLP-1 pill may experience some of the most commonly reported side effects, such as: The Wegovy manufacturer also lists the following commonly reported side effects: headache fatigue dizziness bloating belching gas stomach flu heartburn runny nose sore throat low blood sugar in those with type 2 diabetes It notes that people will react differently to taking Wegovy and advises people to work with a healthcare professional to help them manage any side effects they experience
That era is gone
Notably, pro-inflammatory cytokines are also secreted by visceral adipose tissue in obesity and, together with the inhibition of IRS-1 mediated by TNF-, inhibition of c-Jun N-terminal kinase (JNK) and NK- B inhibitor, serve as major inflammatory mechanisms linking obesity with IR [75, 82]
Health Canada Review Cites 7.1M GLP-1 Prescriptions in 2023 Health Canada's Summary Safety Review discloses 7.1 million GLP-1 receptor agonist prescriptions dispensed by Canadian retail pharmacies in 2023